Associations between Maternal Exposure to Bisphenol A or Triclosan and Gestational Hypertension and Preeclampsia: The MIREC Study

Louopou Rosalie Camara; Tye Elaine Arbuckle; Helen Trottier; William Donald Fraser

doi:10.1055/s-0038-1676489

American Journal of Perinatology, Table of Contents

Am J Perinatol 2019; 36(11): 1127-1135
DOI: 10.1055/s-0038-1676489

Original Article

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Associations between Maternal Exposure to Bisphenol A or Triclosan and Gestational Hypertension and Preeclampsia: The MIREC Study

Louopou Rosalie Camara

¹Social and Preventive Medicine Department, Public Health School, Université de Montréal, Quebec, Canada

²Research Center, CHU Sainte-Justine, Mother and Child University Hospital Center, Montreal, Quebec, Canada

,

Tye Elaine Arbuckle

³Population Studies Division, Environmental Health Science and Research Bureau, Healthy Environments and Consumer Safety Branch, Health Canada, Ottawa, Ontario, Canada

,

Helen Trottier

¹Social and Preventive Medicine Department, Public Health School, Université de Montréal, Quebec, Canada

²Research Center, CHU Sainte-Justine, Mother and Child University Hospital Center, Montreal, Quebec, Canada

,

William Donald Fraser

²Research Center, CHU Sainte-Justine, Mother and Child University Hospital Center, Montreal, Quebec, Canada

⁴CHU Sherbrooke Research Center, Department of Obstetrics and Gynecology, Université de Sherbrooke, Sherbrooke, Quebec, Canada

› Author Affiliations

Abstract

Background Little is known about the association between bisphenol A (BPA) or triclosan (TCS) exposure and hypertension in pregnancy.

Objective To investigate potential associations between maternal urinary concentrations of BPA or TCS and gestational hypertension (GH) and preeclampsia.

Study Design Among 1,909 pregnant women participating in the maternal-infant research on environmental chemicals (MIREC) study, urinary concentrations of BPA and TCS were measured in the first trimester by liquid chromatography-tandem mass spectrometry using isotope dilution. Blood pressure was measured during each trimester. Multinomial regression was performed to estimate the adjusted odds ratio (aOR) and 95% confidence intervals (CI) for the associations between these phenols and GH and preeclampsia.

Results BPA and TCS were not associated with GH or preeclampsia. However, in multiparous women, BPA (0.50–1.30 µg/L) was associated with decreased risk of GH (aOR =0.45; 95%CI: 0.21–0.98) while among nulliparous women, TCS was associated with an increased risk of GH (3.60–32.60 µg/L; aOR = 2.58; 95% CI: 1.09–6.13 and > 32.60 µg/L: aOR = 2.74; 95% CI: 1.15–6.51).

Conclusion BPA and TCS urinary concentrations were not associated with GH or preeclampsia; however, our results suggest an association between TCS and GH in nulliparous women. Additional studies are required to confirm our results.

Keywords

BPA - TCS - gestational hypertension - preeclampsia - pregnancy - pregnant woman - phenols - environmental chemicals

Full Text

References

References
1 Lykke JA, Langhoff-Roos J, Sibai BM, Funai EF, Triche EW, Paidas MJ. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 2009; 53 (06) 944-951
2 Nakimuli A, Nakubulwa S, Kakaire O. , et al. The burden of maternal morbidity and mortality attributable to hypertensive disorders in pregnancy: a prospective cohort study from Uganda. BMC Pregnancy Childbirth 2016; 16: 205
3 Riaz S, Habib S, Jabeen A. Frequency of maternal mortality and morbidity in pregnancy-induced hypertension. J Ayub Med Coll Abbottabad 2011; 23 (04) 61-63
4 Berhan Y, Endeshaw G. Maternal mortality predictors in women with hypertensive disorders of pregnancy: a retrospective cohort study. Ethiop J Health Sci 2015; 25 (01) 89-98
5 Lo JO, Mission JF, Caughey AB. Hypertensive disease of pregnancy and maternal mortality. Curr Opin Obstet Gynecol 2013; 25 (02) 124-132
6 Moodley J. Maternal deaths associated with hypertensive disorders of pregnancy: a population-based study. Hypertens Pregnancy 2004; 23 (03) 247-256
7 Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33 (03) 130-137
8 Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P. ; Canadian Hypertensive Disorders of Pregnancy Working Group Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can 2014; 36 (05) 416-441
9 Wallis AB, Saftlas AF, Hsia J, Atrash HK. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. Am J Hypertens 2008; 21 (05) 521-526
10 Public Health Agency of Canada. Maternal hypertension in Canada. October 2014. Available at: https://www.canada.ca/en/public-health/services/publications/healthy-living/maternal-hypertension-canada.html . Accessed August 16, 2017
11 Ali SM, Khalil RA. Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy. Expert Opin Ther Targets 2015; 19 (11) 1495-1515
12 Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 2011; 123 (24) 2856-2869
13 Robillard PY, Dekker G, Chaouat G. Sixth international workshop on reproductive immunology, immunological tolerance and immunology of preeclampsia. Preface. J Reprod Immunol 2009; 82 (02) 95
14 Robillard PY, Dekker G, Chaouat G, Hulsey TC, Saftlas A. Epidemiological studies on primipaternity and immunology in preeclampsia--a statement after twelve years of workshops. J Reprod Immunol 2011; 89 (02) 104-117
15 Cantonwine DE, Meeker JD, Ferguson KK, Mukherjee B, Hauser R, McElrath TF. Urinary concentrations of bisphenol A and phthalate metabolites measured during pregnancy and risk of preeclampsia. Environ Health Perspect 2016; 124 (10) 1651-1655
16 Pregnancy hypertension. In: Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY, eds. Williams Obstetrics. 23rd edition. New York, NY. McGraw-Hill; 2010:706–756
17 Kobashi G. Genetic and environmental factors associated with the development of hypertension in pregnancy. J Epidemiol 2006; 16 (01) 1-8
18 FDA (U.S. Food and Drug Administration). 5 things to know about triclosan. 2016a. Available at: https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm205999.htm . Accessed July 14, 2017
19 FDA (U.S. Food and Drug Administration). Bisphenol A (BPA): use in food contact application. 2016b. Available at: https://www.fda.gov/newsevents/publichealthfocus/ucm064437.htm . Accessed July 14, 2017
20 GOC (Government of Canada). Triclosan. 2016. Available at: https://www.canada.ca/en/health-canada/services/chemicals-product-safety/triclosan.html . Accessed July 14, 2017
21 GOC (Government of Canada). Bisphenol A in batch 2 of the challenge. 2017. Available at: https://www.canada.ca/en/health-canada/services/chemical-substances/challenge/batch-2/bisphenol-a.html . Accessed July 14, 2017
22 Völkel W, Colnot T, Csanády GA, Filser JG, Dekant W. Metabolism and kinetics of bisphenol a in humans at low doses following oral administration. Chem Res Toxicol 2002; 15 (10) 1281-1287
23 Kang JH, Kondo F, Katayama Y. Human exposure to bisphenol A. Toxicology 2006; 226 (2, 3): 79-89
24 Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human exposure to bisphenol A (BPA). Reprod Toxicol 2007; 24 (02) 139-177
25 von Goetz N, Pirow R, Hart A. , et al. Including non-dietary sources into an exposure assessment of the European Food Safety Authority: The challenge of multi-sector chemicals such as Bisphenol A. Regul Toxicol Pharmacol 2017; 85: 70-78
26 Bae S, Hong YC. Exposure to bisphenol A from drinking canned beverages increases blood pressure: randomized crossover trial. Hypertension 2015; 65 (02) 313-319
27 Shiue I. Higher urinary heavy metal, arsenic, and phthalate concentrations in people with high blood pressure: US NHANES, 2009-2010. Blood Press 2014; 23 (06) 363-369
28 Wang T, Xu M, Xu Y. , et al. Association of bisphenol A exposure with hypertension and early macrovascular diseases in Chinese adults: a cross-sectional study. Medicine (Baltimore) 2015; 94 (43) e1814
29 Leclerc F, Dubois MF, Aris A. Maternal, placental and fetal exposure to bisphenol A in women with and without preeclampsia. Hypertens Pregnancy 2014; 33 (03) 341-348
30 Asimakopoulos AG, Xue J, De Carvalho BP. , et al. Urinary biomarkers of exposure to 57 xenobiotics and its association with oxidative stress in a population in Jeddah, Saudi Arabia. Environ Res 2016; 150: 573-581
31 Rezg R, El-Fazaa S, Gharbi N, Mornagui B. Bisphenol A and human chronic diseases: current evidences, possible mechanisms, and future perspectives. Environ Int 2014; 64: 83-90
32 Aboul Ezz HS, Khadrawy YA, Mourad IM. The effect of bisphenol A on some oxidative stress parameters and acetylcholinesterase activity in the heart of male albino rats. Cytotechnology 2015; 67 (01) 145-155
33 Byun JA, Heo Y, Kim YO, Pyo MY. Bisphenol A-induced downregulation of murine macrophage activities in vitro and ex vivo. Environ Toxicol Pharmacol 2005; 19 (01) 19-24
34 Cindrova-Davies T. Gabor Than Award Lecture 2008: pre-eclampsia–from placental oxidative stress to maternal endothelial dysfunction. Placenta 2009; 30 (Suppl A): S55-S65
35 Myatt L, Cui X. Oxidative stress in the placenta. Histochem Cell Biol 2004; 122 (04) 369-382
36 Reslan OM, Khalil RA. Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia. Cardiovasc Hematol Agents Med Chem 2010; 8 (04) 204-226
37 Khalil RA, Granger JP. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol 2002; 283 (01) R29-R45
38 Bergstrom KG. Update on antibacterial soaps: the FDA takes a second look at triclosans. J Drugs Dermatol 2014; 13 (04) 501-503
39 ECCC (Environment and Climate Change Canada). Canadian environmental protection act, 1999 draft federal environmental quality guidelines, triclosan. 2017. Available at: http://www.ec.gc.ca/ese-ees/default.asp?lang=En&n=F6CF7AA4-1 . Accessed July 14, 2017
40 Cullinan MP, Palmer JE, Faddy MJ. , et al. The influence of triclosan on biomarkers of cardiovascular risk in patients in the cardiovascular and periodontal study (caps): a randomized controlled trial. J Periodontol 2015; 86 (07) 847-855
41 Shiue I. Higher urinary heavy metal, phthalate, and arsenic but not parabens concentrations in people with high blood pressure, U.S. NHANES, 2011-2012. Int J Environ Res Public Health 2014; 11 (06) 5989-5999
42 Shiue I, Hristova K. Higher urinary heavy metal, phthalate and arsenic concentrations accounted for 3–19% of the population attributable risk for high blood pressure: US NHANES, 2009-2012. Hypertens Res 2014; 37 (12) 1075-1081
43 Barros SP, Wirojchanasak S, Barrow DA, Panagakos FS, Devizio W, Offenbacher S. Triclosan inhibition of acute and chronic inflammatory gene pathways. J Clin Periodontol 2010; 37 (05) 412-418
44 Wallet MA, Calderon Nl, Alonso TR. , et al. Triclosan alters antimicrobial and inflammatory responses of epithelial cells. Oral Dis 2013; 19 (03) 296-302
45 Watkins DJ, Ferguson KK, Anzalota Del Toro LV, Alshawabkeh AN, Cordero JF, Meeker JD. Associations between urinary phenol and paraben concentrations and markers of oxidative stress and inflammation among pregnant women in Puerto Rico. Int J Hyg Environ Health 2015; 218 (02) 212-219
46 Lockwood CJ, Yen CF, Basar M. , et al. Preeclampsia-related inflammatory cytokines regulate interleukin-6 expression in human decidual cells. Am J Pathol 2008; 172 (06) 1571-1579
47 Arbuckle TE, Fraser WD, Fisher M. , et al. Cohort profile: the maternal-infant research on environmental chemicals research platform. Paediatr Perinat Epidemiol 2013; 27 (04) 415-425
48 Provencher G, Bérubé R, Dumas P. , et al. Determination of bisphenol A, triclosan and their metabolites in human urine using isotope-dilution liquid chromatography-tandem mass spectrometry. J Chromatogr A 2014; 1348: 97-104
49 Morisset AS, Weiler HA, Dubois L. , et al. Rankings of iron, vitamin D, and calcium intakes in relation to maternal characteristics of pregnant Canadian women. Appl Physiol Nutr Metab 2016; 41 (07) 749-757
50 Arbuckle TE, Marro L, Davis K. , et al. Exposure to free and conjugated forms of bisphenol A and triclosan among pregnant women in the MIREC cohort. Environ Health Perspect 2015; 123 (04) 277-284
51 Bae S, Kim JH, Lim YH, Park HY, Hong YC. Associations of bisphenol A exposure with heart rate variability and blood pressure. Hypertension 2012; 60 (03) 786-793
52 Aekplakorn W, Chailurkit LO, Ongphiphadhanakul B. Association of serum bisphenol a with hypertension in thai population. Int J Hypertens 2015; 2015: 594189
53 Shankar A, Teppala S. Urinary bisphenol A and hypertension in a multiethnic sample of US adults. J Environ Public Health 2012; 2012: 481641
54 Levin KA. Study design III: cross-sectional studies. Evid Based Dent 2006; 7 (01) 24-25
55 Song JW, Chung KC. Observational studies: cohort and case-control studies. Plast Reconstr Surg 2010; 126 (06) 2234-2242
56 Dhingra R, Vasan RS. Age as a risk factor. Med Clin North Am 2012; 96 (01) 87-91
57 Calafat AM, Koch HM, Swan SH. , et al. Misuse of blood serum to assess exposure to bisphenol A and phthalates. Breast Cancer Res 2013; 15 (05) 403
58 Lakind JS, Levesque J, Dumas P, Bryan S, Clarke J, Naiman DQ. Comparing United States and Canadian population exposures from National Biomonitoring Surveys: bisphenol A intake as a case study. J Expo Sci Environ Epidemiol 2012; 22 (03) 219-226
59 Stacy SL, Eliot M, Etzel T. , et al. Patterns, variability, and predictors of urinary triclosan concentrations during pregnancy and childhood. Environ Sci Technol 2017; 51 (11) 6404-6413
60 Lassen TH, Frederiksen H, Kyhl HB. , et al. Prenatal triclosan exposure and anthropometric measures including anogenital distance in Danish infants. Environ Health Perspect 2016; 124 (08) 1261-1268
61 WHO (World Health Organization). Toxicological and health aspects of bisphenol A. 2010. Available at: http://apps.who.int/iris/bitstream/10665/44624/1/97892141564274_eng.pdf . Accessed January 25, 2018
62 Queckenberg C, Meins J, Wachall B. , et al. Absorption, pharmacokinetics, and safety of triclosan after dermal administration. Antimicrob Agents Chemother 2010; 54 (01) 570-572
63 Weiss L, Arbuckle TE, Fisher M. , et al. Temporal variability and sources of triclosan exposure in pregnancy. Int J Hyg Environ Health 2015; 218 (06) 507-513
64 Bertelsen RJ, Engel SM, Jusko TA. , et al. Reliability of triclosan measures in repeated urine samples from Norwegian pregnant women. J Expo Sci Environ Epidemiol 2014; 24 (05) 517-521
65 Fisher M, Arbuckle TE, Mallick R. , et al. Bisphenol A and phthalate metabolite urinary concentrations: daily and across pregnancy variability. J Expo Sci Environ Epidemiol 2015; 25 (03) 231-239

Supplementary Material

Supplementary Material